Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(S)-1-((3S,6S,9S,15S)-1-((3R,8S,11S,14S,17S,20S,23R,26S,29R,34R,40S,43S,46R,49S,52S,55S,60aS,70S,73S,76S,79S,82S)-34-amino-14,20-bis(4-aminobutyl)-52,70,82-tribenzyl-55-((S)-sec-butyl)-40-(2-carboxyethyl)-17-(carboxymethyl)-79-((R)-1-hydroxyethyl)-26,43,76-tris(hydroxymethyl)-11,49,73-triisopropyl-1,10,13,16,19,22,25,28,35,38,41,44,47,50,53,56,66,69,72,75,78,81,84-tricosaoxohexapentacontahydro-29,3-(epiminoethanoiminoethanoiminoethanoiminoethanoiminoethanoiminoethanoiminomethano)-23,46-(methanodithiomethano)pyrrolo[2,1-g][1,2,33,34,5,8,11,14,17,20,23,26,29,38,41,44,47,50,53,56]tetrathiahexadecaazacyclooctapentacontin-8-yl)-9-(2-amino-2-oxoethyl)-15-((S)-sec-butyl)-6-(3-guanidinopropyl)-3-(4-hydroxybenzyl)-1,4,7,10,13-pentaoxo-2,5,8,11,14-pentaazahexadecan-16-oyl)pyrrolidine-2-carboxylic acid
ID: ALA4866985
PubChem CID: 164619674
Max Phase: Preclinical
Molecular Formula: C141H210N36O41S6
Molecular Weight: 3257.84
Molecule Type: Unknown
Associated Items: